Clinical Trials Logo

2-year Disease-Free Survival clinical trials

View clinical trials related to 2-year Disease-Free Survival.

Filter by:
  • None
  • Page 1

NCT ID: NCT03203590 Not yet recruiting - Clinical trials for 2-year Disease-Free Survival

Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC Patients

Start date: September 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficiency and safety of Gefitinib Neoadjuvant Therapy and Oral Navelbine Carboplatin Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢA NSCLC patients with EGFR mutation.